http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-430116-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 |
| filingDate | 1974-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6622dd90c9641c1f9ce4095d36714737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9517cff62a196496a0013e976de02d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcbc98b900fddf6217bdb27c8d3f0d3f |
| publicationDate | 1976-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-430116-A1 |
| titleOfInvention | AN IMPROVED PROCEDURE FOR THE PREPARATION OF CEFALEXINAY AND NON-TOXIC AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE MIS-MA. |
| abstract | An improved process for the preparation of cephalexin and pharmaceutically acceptable and non-toxic salts thereof, comprising the steps of: A) Oxidizing a penicillin produced by fermentation or a salt thereof to produce a penicillinsulfoxide of formula: **(See formula)** where R is the side chain of a penicillin produced by fermentation; B) transposing said penicillin sulfoxide to produce a cephalosporic acid compound of formula **(See formula)** where R is as previously described; C) reacting said cephalosporanic acid compound with a silyl compound of the formula: **(See formula)** where R 2, R 3 and R 5 are hydrogen, halogen, lower alkyl, halo lower alkyl, phenyl, benzyl, tolyl or dimethylamino phenyl, at least one of said groups R2, R3 and r4 being other than halogen or hydrogen; R1 is lower alkyl; m is an integer with a value of 1 or 2 and X is halogen or **(See formula)** where R5 is hydrogen or lower alkyl and R6 is hydrogen, lower alkyl or **(See formula)** where R2, R3 and R4 are as defined above, under anhydrous conditions, in an inert solvent and in the presence of an acid-deactivating tertiary amine, to form the corresponding silyl ester of the cephalosporanic acid compound; D) reacting said silyl ester with an excess of a halogenating agent under anhydrous conditions, in an inert solvent and in the presence of an acid deactivating tertiary amine, to form the corresponding iminohalide; E) reacting with said iminohalide an alcohol selected from aliphatic alcohols of 1 to 12 carbon atoms and phenylalkyl alcohols of 1 to 7 carbon atoms in the alkyl chain, to produce the corresponding iminoether; F) cleaving the imino link of said iminoether by hydrolysis or alcoholysis to produce 7-amino deacetoxy cephalosporic acid; G) preparing the monosilyl or disilyl derivative of 7-amino deacetoxycephalosporanic acid; H) N-acylated said monosilyl or disilyl derivative with a phenylglycine derivative and I) separating by hydrolysis or alcoholysis any silyl group to form cephalexin or by subsequent conversion to form a non-toxic and pharmaceutically acceptable salt thereof; characterized in that: (1) the transposition step, (B) is carried out by heating the free acidic form of penicillinsulfoxide in a weakly basic solvent, in the presence of a catalyst comprising a strong acid either alone or in combination with a nitrogenous base with a pKb not less than 4; (2) The monosilyl derivative of 7-amino deacetoxycephalosporanic acid is prepared by reacting the 7-amino deacetoxycephalosporanic acid product from step (F) with an approximately molar amount of a silyl compound as defined in step (C) or by carrying out the reaction of hydrolysis or alcoholysis of step (F) in the presence of at least an approximately molar excess of a silyl compound as defined in step (C) or subjecting in step (F) the imino bond of the iminoether to alcoholysis and cleavage thermal while in the presence of at least about a molar excess of a silyl compound as defined in step (C); (3) the disilyl derivative of 7-amino deacetoxy-cephalosporanic acid is prepared by reaction of the 7-acid product Amino deacetoxycephalosporanic acid from step (F) with at least 2 moles of a silyl compound as defined in step (C) per mole of 7-amino deacetoxycephalosporanic acid or the reaction is carried out hydrolysis or alcoholysis of step (F) in the presence of at least around a double molar excess of a silyl compound as defined in step (C) or subjecting in step (F) the imino bond of the iminoether to alcoholysis and thermal cleavage while in the presence of at least about a double molar excess of a silyl compound as defined in step (c) and (4), the acylation reaction is carried out by reacting the monosilyl or disilyl derivative with hydrochloride of phenylglycyl chloride in an inert, non-aqueous organic solvent system. (Machine-translation by Google Translate, not legally binding) |
| priorityDate | 1971-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.